Covid19, Covid19 Pneumonia, SARS-CoV 2 Pneumonia
Conditions
Brief summary
The aim of the study is to investigate the efficacy of pulmonary rehabilitation (PR) program to patients with Sars-CoV-2 pneumonia in the post-acute period on pulmonary functions, exercise capacity and anxiety level. 100 patients diagnosed with Sars-CoV-2 pneumonia will be enrolled in this prospective, interventional study according to inclusion/exclusion criteria. Patients will be evaluated and a personalized PR program will be organized before hospital discharge. After discharge, the pulmonary rehabilitation program will continue in telerehabilitation. In the telerehabilitation program, exercises will be supervised by a physiotherapist two days a week, and patients will be asked to do the exercises themselves for the other 3 days. Patients will also receive exercise videos for these 3 days. Patients will be followed for 4 weeks and will be called for final evaluation
Interventions
OTHERPulmonary Rehabilitation
Positioning,breathing techniques (diaphragmatic breathing, alternate breathing, and pursed-lip breathing),respiratory muscle exercises, joint ROM exercises, early-mobilization and progressive ambulation, peripheral muscle strengthening exercises
Sponsors
Sisli Hamidiye Etfal Training and Research Hospital
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Pneumonia without having severe findings or a need for oxygen support therapy (mild pneumonia) accompanying special conditions (chronic lung / heart disease / diabetes / hypertension / neuromuscular disease history / elderly / immobility etc.) * Severe pneumonia (A suspicion of fever or respiratory tract infection and having one accompanying finding: respiration rate \>30/min; severe respiratory distress; or SpO2 ≤93% in ambient air.) cases after they get clinically stable (decreased fever, reduced dyspnea, respiratory rate 90%) * At least 7 days since the diagnosis of SARS-CoV-2 in order to reduce the viral load and the risk of transmission * Being able to make video calls for telerehabilitation
Exclusion criteria
* Serious cardiovascular, cerebrovascular, neuromuscular and other systemic diseases that affect physical activity * Psychiatric illness and cognitive deficit that will affect patient's exercise cooperation * Pregnancy * The deterioration in the general condition of the patient, worsening of the lung findings * Acute respiratory distress syndrome
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Dyspnea level as measured by modified Medical Research Council (mMRC) Dyspnea Scale | 4 weeks | The mMRC scale is a self-rating tool to measure the degree of disability that breathlessness poses on day-to-day activities on a scale from 0 to 4. 0: no breathlessness except on strenuous exercise; 4: too breathless to leave the house, or breathless when dressing or undressing. |
| Change in functional capacity as measured by 30-second sit-to-stand test | 4 weeks | 30 sec- STS determines lower extremity strength and physical fitness in older adults. The number of repetitions is recorded. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in physical activity level as measured by International Physical Activity Questionnaire (IPAQ) -Short Form | 4 weeks | IPAQ-Short Form is used to measure level of physical activity.It consists of 7 questions that provide information about time spent on walking, moderate to vigorous physical activities, and time spent sitting. The energy required for the activities was calculated by the MET-minute/week score. Standard MET values for these activities are: Walking = 3,3 METS; Moderate Physical Activity = 4,0 METS; Vigorous Physical Activity = 8.0 METS; Sitting = 1,5 METS |
| Change in anxiety and depression as measured by Hospital Anxiety and Depression Scale (HADS) | 4 weeks | HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression.The total scores range is 0-21 for both depression and anxiety scores. A higher score indicates a worse depression and anxiety. |
Countries
Turkey (Türkiye)
Contacts
Primary ContactEnes Efe Is, MD
Outcome results
None listed